Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 26, 2018 07:30 ET | Source: Chimerix, Inc.

Chimerix to Present at Cantor Fitzgerald Global Healthcare Conference

DURHAM, N.C., Sept. 26, 2018 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company developing novel antivirals to address unmet medical needs, today announced that M. Michelle...
August 29, 2018 07:00 ET | Source: Chimerix, Inc.

Chimerix to Participate in September Investor Conferences

DURHAM, N.C., Aug. 29, 2018 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company developing novel antivirals to address unmet medical needs, today announced that company...
August 08, 2018 07:00 ET | Source: Chimerix, Inc.

Chimerix Announces Second Quarter 2018 Financial Results

DURHAM, N.C., Aug. 08, 2018 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company developing novel antivirals to address unmet medical needs, today reported financial results and...
August 01, 2018 08:00 ET | Source: Chimerix, Inc.

Chimerix to Announce Second Quarter 2018 Financial Results on August 8, 2018

DURHAM, N.C., Aug. 01, 2018 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company developing novel antivirals to address unmet medical needs, today announced that it will host a...
June 12, 2018 07:00 ET | Source: Chimerix, Inc.

Chimerix Announces Discovery and Demonstrated Preclinical Activity Supporting Ongoing Phase 1 Study of New Antiviral for Treatment and Prevention of Norovirus

- CMX521 is Active In Vitro Against All Strains of Norovirus Tested - - Oral Dosing of CMX521 Inhibited Norovirus Replication in Animal Model - DURHAM, N.C., June 12, 2018 (GLOBE NEWSWIRE) --...
June 07, 2018 07:30 ET | Source: Chimerix, Inc.

Chimerix Receives Orphan Drug Designation from the FDA for Brincidofovir for the Treatment of Smallpox

DURHAM, N.C., June 07, 2018 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company developing novel antivirals to address unmet medical needs, today announced that the U.S. Food and...
June 05, 2018 17:29 ET | Source: Chimerix, Inc.

Chimerix to Address Congressional Subcommittee in Support of Reauthorization of the Pandemic and All-Hazards Preparedness Act (PAHPA)

DURHAM, N.C., June 05, 2018 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company developing novel antivirals to address unmet medical needs, announced that President and Chief...
May 07, 2018 07:00 ET | Source: Chimerix, Inc.

Chimerix Announces First Quarter 2018 Financial Results

- Landmark AdVance Study Demonstrates Strong Correlation Between Adenovirus Burden and Mortality Risk - - Site Initiations for AdAPT Study of Oral Short-course Brincidofovir for Adenovirus and IV...
May 02, 2018 08:00 ET | Source: Chimerix, Inc.

Chimerix to Present at the Deutsche Bank 43rd Annual Health Care Conference

DURHAM, N.C., May 02, 2018 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company developing novel antivirals for the growing population of immunocompromised patients, today...
April 30, 2018 08:00 ET | Source: Chimerix, Inc.

Chimerix to Announce First Quarter 2018 Financial Results on May 7, 2018

DURHAM, N.C., April 30, 2018 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company developing novel antivirals for the growing population of immunocompromised patients, today...